Israel-based investor, The Trendlines Group, has sold its 26.9%-owned (fully diluted) portfolio company, OrthoSpin, to Synthes (part of DePuy Synthes, the Orthopaedics company of Johnson & Johnson) as part of the US$79.5m acquisition. The cash…
Israel-based investor, The Trendlines Group, has sold its 26.9%-owned (fully diluted) portfolio company, OrthoSpin, to Synthes (part of DePuy Synthes, the Orthopaedics company of Johnson & Johnson) as part of the US$79.5m acquisition. The cash…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


